Nigel Lange

Chief Executive, Managing Director / OncoSil Medical

Nigel Lange has over 30 years of experience in the medical devices industry.

He joined OncoSil in May 2020 as EMEA president and became chief executive in January 2021.

Mr Lange had held various leadership roles during his 15-year tenure with Sirtex Medical, a company involved in brachytherapy treatment for liver cancer. He was chief executive of Sirtex's European business, responsible for establishing their brachytherapy device in over 300 centres across Europe and Middle East; group chief commercial officer where he was responsible for all commercial aspects of the global business; as well as interim roles including interim group chief executive and interim chief executive of Asia Pacific.

Lists and Charts

Roles

2021

Chief Executive, Managing Director

OncoSil Medical

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
927^th	Comet Ridge	-5.71%	-3.29%
928^th	Nova Minerals	-5.77%	-5.78%
929^th	OncoSil Medical	-5.87%	-43.38%
930^th	Kaiser Reef	-5.88%	0%
931^st	Jcurve Solutions	-5.88%	4.42%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

NEW ROLE: Chief Executive, Managing Director, OncoSil Medical

14 Apr 2021

Related Information

Access to our data for Nigel Lange is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Nigel Lange is linked to 2 organisations which are included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.